Notice: This company has been marked as potentially delisted and may not be actively trading. Vallon Pharmaceuticals (VLON) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends VLON vs. CPIX, VRCA, XLO, BIVI, RNXT, IXHL, XCUR, LEXX, MRNS, and CMMBShould you be buying Vallon Pharmaceuticals stock or one of its competitors? The main competitors of Vallon Pharmaceuticals include Cumberland Pharmaceuticals (CPIX), Verrica Pharmaceuticals (VRCA), Xilio Therapeutics (XLO), BioVie (BIVI), RenovoRx (RNXT), Incannex Healthcare (IXHL), Exicure (XCUR), Lexaria Bioscience (LEXX), Marinus Pharmaceuticals (MRNS), and Chemomab Therapeutics (CMMB). These companies are all part of the "pharmaceutical preparations" industry. Vallon Pharmaceuticals vs. Cumberland Pharmaceuticals Verrica Pharmaceuticals Xilio Therapeutics BioVie RenovoRx Incannex Healthcare Exicure Lexaria Bioscience Marinus Pharmaceuticals Chemomab Therapeutics Cumberland Pharmaceuticals (NASDAQ:CPIX) and Vallon Pharmaceuticals (NASDAQ:VLON) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, dividends, valuation and risk. Is CPIX or VLON more profitable? Vallon Pharmaceuticals has a net margin of 0.00% compared to Cumberland Pharmaceuticals' net margin of -29.54%. Cumberland Pharmaceuticals' return on equity of -9.50% beat Vallon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Cumberland Pharmaceuticals-29.54% -9.50% -3.19% Vallon Pharmaceuticals N/A -230.48%-124.89% Does the MarketBeat Community prefer CPIX or VLON? Cumberland Pharmaceuticals received 186 more outperform votes than Vallon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Vallon Pharmaceuticals an outperform vote while only 41.74% of users gave Cumberland Pharmaceuticals an outperform vote. CompanyUnderperformOutperformCumberland PharmaceuticalsOutperform Votes18741.74% Underperform Votes26158.26% Vallon PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo Votes Which has more risk and volatility, CPIX or VLON? Cumberland Pharmaceuticals has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. Comparatively, Vallon Pharmaceuticals has a beta of -1.14, suggesting that its share price is 214% less volatile than the S&P 500. Which has higher earnings & valuation, CPIX or VLON? Cumberland Pharmaceuticals has higher revenue and earnings than Vallon Pharmaceuticals. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Vallon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCumberland Pharmaceuticals$39.55M0.80-$6.28M-$0.77-2.92Vallon Pharmaceuticals$100K84.94-$7.02M-$0.78-0.81 Does the media favor CPIX or VLON? In the previous week, Cumberland Pharmaceuticals had 4 more articles in the media than Vallon Pharmaceuticals. MarketBeat recorded 4 mentions for Cumberland Pharmaceuticals and 0 mentions for Vallon Pharmaceuticals. Cumberland Pharmaceuticals' average media sentiment score of 0.72 beat Vallon Pharmaceuticals' score of 0.00 indicating that Cumberland Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Cumberland Pharmaceuticals Positive Vallon Pharmaceuticals Neutral Do insiders & institutionals hold more shares of CPIX or VLON? 15.5% of Cumberland Pharmaceuticals shares are owned by institutional investors. Comparatively, 8.7% of Vallon Pharmaceuticals shares are owned by institutional investors. 43.3% of Cumberland Pharmaceuticals shares are owned by company insiders. Comparatively, 37.3% of Vallon Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryCumberland Pharmaceuticals beats Vallon Pharmaceuticals on 11 of the 15 factors compared between the two stocks. Get Vallon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLON vs. The Competition Export to ExcelMetricVallon PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.49M$6.93B$5.62B$9.14BDividend YieldN/A2.95%5.36%3.98%P/E Ratio-0.8110.1189.6917.66Price / Sales84.94351.361,220.3881.09Price / CashN/A65.4844.3437.71Price / Book3.505.335.134.73Net Income-$7.02M$157.56M$118.85M$225.42M Vallon Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLONVallon PharmaceuticalsN/A$0.63flatN/A+64.9%$8.49M$100,000.00-0.813Gap DownCPIXCumberland Pharmaceuticals0.6154 of 5 stars$2.36-8.9%N/A+9.3%$33.13M$39.55M-3.0680Short Interest ↓News CoverageGap DownVRCAVerrica Pharmaceuticals4.6128 of 5 stars$0.72-0.9%$9.50+1,226.8%-88.0%$32.65M$5.12M-0.3940Positive NewsXLOXilio Therapeutics3.6877 of 5 stars$0.72-12.0%$4.00+454.0%+7.0%$31.74M$4.62M-0.4270Short Interest ↓Gap UpBIVIBioVie1.9384 of 5 stars$1.78-7.8%$3.00+68.5%+68.0%$31.63MN/A-0.1510Short Interest ↓RNXTRenovoRx2.0231 of 5 stars$1.32-4.7%$6.50+394.3%+12.4%$31.56MN/A-2.316IXHLIncannex Healthcare1.0297 of 5 stars$1.68-4.0%N/A-54.8%$30.88M$86,000.00-1.213Short Interest ↓XCURExicure1.8044 of 5 stars$11.72-2.5%N/A+1,857.3%$30.54M$500,000.00-5.6650Short Interest ↓Gap UpLEXXLexaria Bioscience3.3088 of 5 stars$1.73-0.6%$9.50+449.1%+20.7%$30.36M$460,000.00-3.467Short Interest ↑Analyst RevisionNews CoverageGap UpMRNSMarinus Pharmaceuticals4.4196 of 5 stars$0.54+0.1%$4.79+781.8%-94.7%$29.97M$30.99M-0.22110Analyst ForecastShort Interest ↓CMMBChemomab Therapeutics3.5706 of 5 stars$2.08flat$7.50+260.6%+281.5%$29.87MN/A-2.0820Positive News Related Companies and Tools Related Companies CPIX Alternatives VRCA Alternatives XLO Alternatives BIVI Alternatives RNXT Alternatives IXHL Alternatives XCUR Alternatives LEXX Alternatives MRNS Alternatives CMMB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VLON) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vallon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vallon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VLON Stock Alerts